OXALACT
"OXALACT" is a word mark owned by Alnylam Pharmaceuticals, Inc., filed at the IPI on July 4, 2024. It is registered and covers classes 42 and 44.
- Status
- Registered
- Filed
- July 4, 2024
- Registered
- August 16, 2024
- Expires
- July 4, 2034
- Application no.
- 09536/2024
- Registration no.
- 818805
- Office
- IPI
- Swiss Federal Institute of Intellectual Property
- Mark type
- Word mark
- 2 classes
Who owns OXALACT
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Alnylam Pharmaceuticals, Inc.
ALNY · United States
Representative
Weinmann Zimmerli
What the mark covers
The products and services OXALACT is filed for, grouped by Nice class.
Durchführung von biochemischen Tests für wissenschaftliche Forschungszwecke.
Medizinische Untersuchungen zu Diagnose- oder Behandlungszwecken; Durchführung von biochemischen Tests zu Diagnose- oder Behandlungszwecken.
What has happened so far
Steps recorded by the IPI, newest first.
- Change of name and/or address of representative
- Registration
About OXALACT
Who owns the trademark "OXALACT"?
The IPI trademark "OXALACT" (application 09536/2024) is owned by Alnylam Pharmaceuticals, Inc.
What is the status of "OXALACT"?
Its status at the IPI is: registered.
When was "OXALACT" registered?
It was registered on August 16, 2024 and is due to expire on July 4, 2034.
Get this data via the API
Everything on this page comes from the Signa API. Pull OXALACT and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019eb694-532e-7329-a4df-cc0c1d504e97
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019eb694-532e-7329-a4df-cc0c1d504e97",
"object": "trademark",
"mark_text": "OXALACT",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CH",
"application_number": "09536/2024",
"filing_date": "2024-07-04",
"nice_classes": [
42,
44
],
"owners": [
{
"name": "Alnylam Pharmaceuticals, Inc.",
"entity_id": "ent_019eb709-7d9a-70dc-b19d-2c56e8a223b5"
}
]
}